Status epilepticus
For what are we waiting?
Status epilepticus (SE) is a common pediatric neurologic emergency with an incidence of 10-38 per 100,000 children per year, associated with substantial morbidity and mortality. 1 An operational definition of SE, sometimes called impending SE, occurs when a seizure or a series of seizures without intervening recovery of consciousness lasts 5-10 minutes. By the traditional definition, SE is not established until the duration reaches 30 minutes. Refractory SE occurs when an adequately dosed initial benzodiazepine and one other antiseizure medication have failed to stop the seizure. 2 The overall short-term mortality of convulsive SE in children is notable at 3%-5% 3 and is at least twice as high for refractory SE. 4 Overall morbidity for convulsive SE in children is 10%-30% and over 50% for refractory SE. 3 These data indicate that longer seizures result in worse outcomes.
Published guidelines for treating seizures exceeding 5 minutes recognize the higher morbidity and mortality associated with progressively longer seizures. They emphasize the need to administer medications by defined time points. 5 Patients with prolonged seizures should receive their first medication, typically a benzodiazepine, once a seizure or series of seizures lasts 5 minutes. They should receive a nonbenzodiazepine medication by the time a seizure has lasted 20 minutes. The recommendation to switch to a nonbenzodiazepine medication after 2 benzodiazepine doses reflects the lower efficacy of the benzodiazepine class of medications as seizures persist. 6 Despite the strong rationale for these published SE treatment guidelines, few studies have addressed how well these guidelines are followed in practice. In FEBSTAT, a prospective observational study of febrile SE, children received their first antiseizure medication at a median time of 30 minutes after seizure onset. 7 However, no studies have systematically examined when patients with SE actually receive each dose of benzodiazepine and nonbenzodiazepine medications. In this issue of Neurology ® , Sánchez Fernández et al. 8 have used the pediatric Status Epilepticus Research Group (pSERG) to address these issues using a prospective observational cohort. They enrolled 81 patients with a median age of 3.6 years (interquartile range 1.2-8.8) with focal or generalized convulsive seizures at onset that did not respond to 2 or more antiseizure medications or required the initiation of a continuous infusion of a medication. As might be expected in such a group of patients, 98% were admitted to an intensive care unit, and 75% were intubated. The principal finding is that medication administration during SE is substantially delayed compared to the published guidelines. Specifically, patients received the first, second, and third medication doses at a median of 28 (6-67), 40 (20-85), and 59 (30-120) minutes after seizure onset. Ninety-six percent of patients received a benzodiazepine first. Eighty-eight percent received at least 2 benzodiazepine doses and 49% received at least 3 doses. Patients received their first and second benzodiazepine doses at a median of 30 (6-70) and 40 (20-95) minutes after seizure onset. They received their first and second doses of a nonbenzodiazepine at a median of 69 (40-120) and 120 (75-296) minutes after seizure onset. For patients whose seizures began outside of the hospital, these delays in medication administration remained when the time of medication administration was determined relative to the time of hospital arrival. With this adjustment, patients received the first and second medication doses at a median of 8 (5-15) and 16 (10-40) minutes after seizure onset for inpatients or hospital arrival for patients whose seizures started outside of a hospital. Seizure duration correlated with the time at which patients received the first, second, and third medications.
The delay in medication administration was especially striking in the 64 patients whose seizures began outside of a hospital. Only 25% of these patients received their first medication dose by 20 minutes after seizure onset. Only 38% received a medication in the field. In these 64 patients, time of medication administration did not differ between patients who initially presented to a pSERG and a non-pSERG hospital.
This study establishes that delayed medication administration and administration of too many benzodiazepine doses occur during SE treatment at leading children's hospitals in the United States, but important questions remain unanswered. The study does not establish the overall frequency of delayed medication administration during pediatric SE, because it only includes patients with refractory convulsive SE. Patients who received medications in a timely manner and whose seizures stopped were not included. Patients who received medications late but whose seizures stopped also were not included. As the authors acknowledge, the risk of refractory SE when treatment is delayed remains unknown. These factors may limit the generalizability of the results. The study also does not identify the reasons for the delay.
Despite the possibility that strict adherence to SE treatment guidelines may not always affect outcome, 9 we as neurologists should address these shortcomings in SE treatment identified by these investigators. We can educate parents, caregivers, first responders, physicians, and other health care providers about SE and the need to treat aggressively. We must provide parents and caregivers with a seizure action plan for treating seizures exceeding a threshold duration such as 5 minutes. Typically, the plan will involve administering a benzodiazepine. We must require first responders, physicians, and other health care providers to treat SE as a code with specific guidelines for them to implement, and we must ensure for our inpatients that we are following our own hospital protocols for on-time administration of antiseizure medications. We must empower first responders to treat prolonged seizures by providing them with the best medications and allowing them to administer these medications via the most effective route. 7, 10 Like stroke, time likely is brain when it comes to SE.
